Once-Weekly Basal Insulin Fc Demonstrated Similar Glycemic Control to Once-Daily Insulin Degludec in Insulin-Naive Patients With Type 2 Diabetes: A Phase 2 Randomized Control Trial

Safety and efficacy of once-weekly basal insulin Fc in people with type 2 diabetes previously treated with basal insulin: a multicentre, open-label, randomised, phase 2 study

(2023) Juan Frias et al.   Lancet Diabetes & Endocrinology

Pharmacokinetic and pharmacodynamic properties of the novel basal insulin Fc (insulin efsitora alfa), an insulin fusion protein in development for once‐weekly dosing for the treatment of patients with diabetes

(2022) Tim Heise et al.   DIABETES OBESITY & METABOLISM

Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial

(2021) Harpreet S. Bajaj et al.   DIABETES CARE

A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100

(2021) Ildiko Lingvay et al.   DIABETES CARE

The future of insulin therapy

(2021) Tim Heise   DIABETES RESEARCH AND CLINICAL PRACTICE

Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing

(2021) Erica Nishimura et al.   BMJ Open Diabetes Research & Care

6. Glycemic Targets: Standards of Medical Care in Diabetes—2022

(2021)   DIABETES CARE

Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment

(2020) Julio Rosenstock et al.   NEW ENGLAND JOURNAL OF MEDICINE

Key factors for overcoming psychological insulin resistance: an examination of patient perspectives through content analysis

(2019) Heather Stuckey et al.   BMJ Open Diabetes Research & Care

Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany

(2016) Karel Kostev et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long)

(2012) B. Zinman et al.   DIABETES CARE

Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study

(2012) John B Buse et al.   LANCET